IBM (IBM) – Research Analysts’ Recent Ratings Updates
IBM (NYSE: IBM) received a number of ratings updates from brokerages and research firms in the last week:
- IBM had its “market perform” rating reaffirmed by analysts at BMO Capital Markets. They now have a $205.00 price target on the stock.
- IBM had its “buy” rating reaffirmed by analysts at Sterne Agee. They now have a $230.00 price target on the stock.
- IBM had its “neutral” rating reaffirmed by analysts at Zacks. They now have a $214.00 price target on the stock.
- IBM had its “sector perform” rating reaffirmed by analysts at RBC Capital. They now have a $215.00 price target on the stock.
- IBM had its price target raised by analysts at Deutsche Bank from $225.00 to $240.00. They now have a “buy” rating on the stock. They wrote, “IBM’s recently refreshed mainframe and a POWER7+ server refresh in early October should support re-accelerating hardware growth in the near term. The HW refresh should also drive improving growth in Services and Software revenue (5-6% growth historically over past 5 cycles) and drive improving margins. We believe these factors are not reflected in consensus estimates and we raise our FY13 EPS est to $17 (vs. prior $16.60 and raise our PT to $240. With IBM currently trading at 13x FY13E we view shares as attractively valued.”
IBM opened at 210.51 on Thursday. IBM has a 1-year low of $175.66 and a 1-year high of $211.75. The company has a market cap of $240.6 billion and a price-to-earnings ratio of 15.24.
International Business Machines Corporation (IBM) is an information technology (IT) company. IBM operates in five segments: Global Technology Services (GTS), Global Business Services (GBS), Software, Systems and Technology and Global Financing.